Stories about Arthritis

13.02.2026 – 10:01
STADA Arzneimittel AG
Press Release: STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi - European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA ...
One document
more
12.02.2021 – 09:43
Technische Universität München
New synthetic peptides could attenuate atherosclerosis
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36446/ NEWS RELEASE New synthetic peptides could attenuate atherosclerosis Synthetic “mini” receptors block atherosclerosis Atherosclerosis, a lipid-triggered chronic inflammatory disease of our arteries, is the main cause of strokes and ...
more